Introduction: Hepatitis B virus (HBV) infection remains a concern in dialysis populations where vaccination has been less successful than in the general population. Possible reasons for poor response to vaccination in this population include malnutrition, age, uraemia, dialysis vintage, human immunodeficiency virus (HIV) infection and the generalized immunosuppressive state of patients with chronic kidney disease (CKD).Methods: This retrospective point prevalent cohort study evaluated the prevalence of HBV infection in a dialysis population at a tertiary centre in South Africa where there is a high prevalence of HIV. In addition, antibody responses following natural HBV infection versus vaccination were examined in the same population as we...
Background: The prevalence and incidence rates of hepatitis B virus (HBV) among patients undergoing ...
Summary: The prevalence of end-stage renal disease has increased dramatically in developing countrie...
OBJECTIVES: Data on the factors that contribute to the antibody response to hepatitis B virus vaccin...
Background: In addition to severe renal impotence and decline of immune status, the high prevalence ...
INTRODUCTION : Hepatitis B virus (HBV) infection is an important health problem worldwide and more...
Background: Hepatitis B Virus (HBV) infection is considered as a major cause of liver cirrhosis and...
Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are widespread health pro...
Introduction: End stage renal disease (ESRD) has become a universal public health problem. Chronic k...
Background Due to its invasive procedure patients on hemodialysis (HD) are at high risk of infecti...
Patients on hemodialysis therapy are at a relatively high risk of exposure to hepatitis-B virus (HBV...
Haemodialysis patients are at increased risk of exposure to blood borne viruses. To reduce transmiss...
Introduction: Hemodialysis patients usually demonstrate lower immune response to hepatitis B vaccine...
Background. Vaccination against hepatitis B virus is an important means of controlling the infection...
ABSTRACT Background: Experience of hepatitis B vaccination in a contemporary renal replacement progr...
Introduction: Blood-borne viral infections are a major public health problem, especially in high-ris...
Background: The prevalence and incidence rates of hepatitis B virus (HBV) among patients undergoing ...
Summary: The prevalence of end-stage renal disease has increased dramatically in developing countrie...
OBJECTIVES: Data on the factors that contribute to the antibody response to hepatitis B virus vaccin...
Background: In addition to severe renal impotence and decline of immune status, the high prevalence ...
INTRODUCTION : Hepatitis B virus (HBV) infection is an important health problem worldwide and more...
Background: Hepatitis B Virus (HBV) infection is considered as a major cause of liver cirrhosis and...
Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are widespread health pro...
Introduction: End stage renal disease (ESRD) has become a universal public health problem. Chronic k...
Background Due to its invasive procedure patients on hemodialysis (HD) are at high risk of infecti...
Patients on hemodialysis therapy are at a relatively high risk of exposure to hepatitis-B virus (HBV...
Haemodialysis patients are at increased risk of exposure to blood borne viruses. To reduce transmiss...
Introduction: Hemodialysis patients usually demonstrate lower immune response to hepatitis B vaccine...
Background. Vaccination against hepatitis B virus is an important means of controlling the infection...
ABSTRACT Background: Experience of hepatitis B vaccination in a contemporary renal replacement progr...
Introduction: Blood-borne viral infections are a major public health problem, especially in high-ris...
Background: The prevalence and incidence rates of hepatitis B virus (HBV) among patients undergoing ...
Summary: The prevalence of end-stage renal disease has increased dramatically in developing countrie...
OBJECTIVES: Data on the factors that contribute to the antibody response to hepatitis B virus vaccin...